Shopping Cart

Appendix 4C for Q3 2017

Appendix 4C for Q3 2017

In accord with ASX requirements, Imagion Biosystems has lodged “Appendix 4C, Quarterly report for entities subject to Listing Rule 4.7B” for the Quarter ended 30 September 2017.
View Appendix 4C for Q3, 2017.

Related Articles

2023 AGM Resolution Overview

Video Transcript: Robert Proulx, Imagion Biosystems’ President & CEO: [00:00:00] On April 24th, we sent out the notice of meeting for our annual general meeting

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.